Lumbrokinase attenuates myocardial ischemia/reperfusion injury by inhibiting TLR4 signaling
碩士 === 中山醫學大學 === 醫學研究所 === 102 === Lumbrokinase, an antithrombotic agent, extracted from Lumbricus rubellus, has been used to prevent and treat stroke and cardiovascular diseases in clinical. It has been reported that lumbrokinase has some pharmacological properties, including anti-inflammatory, a...
Main Authors: | Hsiao-Ting Wang, 王筱婷 |
---|---|
Other Authors: | Jinghua Tsai Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/04352264063726694394 |
Similar Items
-
Therapeutic effect of lumbrokinase on ischemia-reperfusion injury
by: Yi-Hsin Wang, et al.
Published: (2018) -
Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury
by: Yi-Hsin Wang, et al.
Published: (2018-06-01) -
TLR2 and TLR4 in Ischemia Reperfusion Injury
by: F. Arslan, et al.
Published: (2010-01-01) -
Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury
by: Kapil Suchal, et al.
Published: (2016-01-01) -
Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway
by: Iman O. Sherif, et al.
Published: (2018-01-01)